Pharmacological Considerations in the Treatment of Myasthenia Gravis
- 1 January 1963
- book chapter
- Published by Elsevier
- Vol. 2, 113-160
- https://doi.org/10.1016/s1054-3589(08)60086-1
Abstract
No abstract availableThis publication has 107 references indexed in Scilit:
- THE FINE STRUCTURAL LOCALIZATION OF ACETYLCHOLINESTERASE AT THE MYONEURAL JUNCTIONThe Journal of cell biology, 1962
- THE ULTRASTRUCTURE OF HUMAN MYASTHENIC AND NON-MYASTHENIC MOTOR END PLATESBrain, 1960
- Isolation and identification of the acetylcholine receptor protein of electric tissueBiochimica et Biophysica Acta, 1960
- Tumours of the thyroid gland in relation to some general concepts of neoplasiaJournal of the Faculty of Radiologists, 1959
- The identity of 'intrinsic’ and ‘extrinsic’ acetylcholine receptors in the motor end-plateProceedings of the Royal Society of London. B. Biological Sciences, 1957
- The Mode of Neuromuscular Block Caused by Acetylcholine, Nicotine, Decamethonium and Suecinylcholine1Acta Physiologica Scandinavica, 1955
- Experimentelle Untersuchungen zur Pathogenese der MyasthenieZeitschrift für Die Gesamte Experimentelle Medizin, 1955
- A powerful reactivator of alkylphosphate-inhibited acetylcholinesteraseBiochimica et Biophysica Acta, 1955
- MYASTHENIA GRAVIS TREATED WITH LARGE DOSES OF NEOSTIGMINE METHYLSULFATE, INTEAMUSCDLAELY AND INTRAVENOUSLY, AND WITH NEOSTIGMINE BROMIDE ORALLYThe Lancet Healthy Longevity, 1944
- Ueber einen scheinbar heilbaren bulbärparalytischen Symptomencomplex mit Betheiligung der ExtremitätenZeitschrift für Neurologie, 1893